A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis. (Q35800226)
Jump to navigation
Jump to search
scientific article published on 6 October 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis. |
scientific article published on 6 October 2015 |
Statements
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis (English)
Richard N Greenberg
Maria Yadira Hurley
Dinh V Dinh
Serena Mraz
Javier Gomez Vera
Dorothea von Bredow
Alfred von Krempelhuber
Siegfried Roesch
Garth Virgin
Nathaly Arndtz-Wiedemann
Thomas Peter Meyer
Darja Schmidt
Philip Young
6 October 2015
6 October 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference